The strategy aims to triple revenue by leveraging new resources and expanding the company’s reach in the food rescue market.
Dec 19
MinusSugar, a biotech startup founded by a Brazilian team in Miami, raised US$2.5 million in funding, led by BR Angels.
The company has developed a proprietary process to remove sugar from fruit juices while preserving flavor, nutrition, and freshness. The funds will be used for research and development, particularly to scale its technology in a pilot plant.
Dec 17
Sami, a healthtech focused on preventive care, raised R$60 million in an extension of its Series B round to accelerate its growth in 2025. The investment was led by Mundi Ventures and StoneX, alongside existing investors such as Monashees and Valor Capital.
Sami plans to boost its product offerings, expand in São Paulo’s east zone, and improve its copayment model, which already accounts for 90% of new clients.
Dec 16
Trinus.Co, a Goiás-based company linking real estate and financial markets, received a R$43 million investment from Bewater, expanding its Series B funding round. The company plans to enhance its tech platform, scale operations, and support acquisitions.
Operating since 2009, Trinus focuses on empowering regional real estate entrepreneurs with technology and financial resources.
Dec 16
Nubank invested US$150 million in Tyme Group, a neobank focused on Africa and Asia.
The Series D round reached US$250 million (US$50 million from M&G Catalyst Group, and an additional $50 million from existing shareholders).
Founded in South Africa in 2019, Tyme operates in the Philippines and serves 15 million customers. The deal aligns with Nubank’s goal to support accessible, cost-efficient banking models and strengthens Tyme’s expansion plans.
Dec 13
Nintx, a biotech company researching and developing treatments for multifactorial diseases using Brazil’s biodiversity, has raised US$10 million in a Series A round, led by Pitanga, Ecoa Capital, and MOV Investimentos, along with a $2.5 million grant from FINEP.
The funds will accelerate the development of eight new drug programs, research partnerships, and expansion efforts.
Nintx employs innovative approaches to treating multifactorial diseases, leveraging proprietary technologies like xGI biomics® and GAIA path® to advance therapies. The company aims to license its first drug candidate within three years.
Dec 4
Zig, a fintech specializing in entertainment solutions, raised R$155 million in an extended Series B round, led by Kaszek Ventures.
This follows an earlier round where the company secured R$ 110 million from other investors. The funding will fuel Zig’s expansion into bars, nightclubs, and events outside Brazil’s Southeast, as well as boost its international presence in Mexico, Portugal, and Spain.
Dec 4
Resend, specializing in global communication solutions, has secured US$18 million led by Andreessen Horowitz.
Founded by Brazilians living in Silicon Valley, the company is growing about 15% monthly and has 3.700 paying clients.
Dec 3
Klubi, a fintech specializing in consortia, raised R$45 million in a Series A round led by L4 Venture Builder, with participation from Vivo Ventures. Founded in 2019 and licensed by the Central Bank in 2020, Klubi focuses primarily on vehicle and mobile phone consortia.
Dec 3
Onze, a startup in private pension and financial health solutions, raised R$ 110 million in a new funding round led by Ribbit (Nubank’s investor), with participation of Atlantico and Red Ventures. The investment will help expand the company’s presence in the national market, focusing on medium and large businesses. Additionally, funds aim to enhance products like collateralized credit and improve financial well-being solutions for companies and employees.
News gathering by Thais Chertman
